The new treatment option aims at providing good glycaemic control with fewer injections than a basal-bolus regimen
The new treatment option aims at providing good glycaemic control with fewer injections than a basal-bolus regimen
Cosentyx is the only biologic that can be used as first-line systemic therapy in the treatment of psoriasis and as…
Of the total amount, $5.65 million would be towards the purchase of the facility building which is currently leased to…
To research immuno-oncology combination regimens in multiple types of cancer
E-Magic Plus provides the latest technology in combining ultra-thin strut of a CoCr stent, with an optimal Sirolimus coating
Visits India to showcase their capabilities and enhance relationships with their Indian as part of Australia Business Week in India
The product has been introduced pan India
To distribute LiquidBiopsy platform
Novartis has approved the sale of its OTC Division to GlaxoSmithKline Consumer for Rs 1097.3 million. It may be noted…
The MOHFW launched the Filaria Free India campaign through mass media and community-based channels ahead of mass drug administrations that…
Strides Arcolab announced that its wholly owned subsidiary Strides Pharma Global Pte. Ltd. Singapore (Strides Pharma Global) has been awarded…
The CMO Leadership Awards are based on industry leading research conducted by Nice Insight
Partnership includes both a broad R&D collaboration with the potential for more than USD 150 million funding by Roche to…
The agreement will allow MedImmune to combine key agents from its investigational immunotherapy portfolio with Omnis’ lead investigational oncolytic virus…
Facility to augment economic growth in the region
Date: February 18, 2015 Venue: Hotel Le Meridien, New Delhi
Study shows hi-tech engineering, pharma as front runners of innovation in India
The new partnership will cover domestic products within the Indian market, with expected roll-out in Q1 of 2015